Fifteen-year results of the randomised EORTC trial 22922/10925 investigating internal mammary and medial supraclavicular (IM-MS) lymph node irradiation in stage I-III breast cancer.

被引：13

作者：

Poortmans, Philip

Collette, Sandra

Struikmans, Henk

De Winter, Karin

Van Limbergen, Erik

Kirkove, Carine

Budach, Volker

Peignaux-Casasnovas, Karine

Vonk, Ernest

Vandenbongard, Desiree D.

Rivera, Sofia

Zips, Daniel

Van Tienhoven, Geertjan

Guckenberger, Matthias

Abdah-Bortnyak, Roxolyana

Fourquet, Alain

Bartelink, Harry G. M.

机构：

[1] Inst Curie, Paris, France

[2] Eur Org Res & Treatment Canc, Brussels, Belgium

[3] MCHaaglanden, The Hague, Netherlands

[4] Inst Verbeeten, Tilburg, Netherlands

[5] Univ Hosp Gasthuisberg, Leuven, Belgium

[6] Univ Hosp St Luc, Woluwe St Lambert, Belgium

[7] Charite, Comprehens Canc Ctr, Dept Radiat Oncol & Radiotherapy, Berlin, Germany

[8] Georges Francois Leclerc Canc Ctr, Dijon, France

[9] Radiotherapiegrp, Deventer, Netherlands

[10] Univ Med Ctr Utrecht, Utrecht, Netherlands

[11] Gustave Roussy, Dept Radiat Therapy, Villejuif, France

[12] German Canc Res Ctr, Heidelberg & German Canc Consortium DKTK, Partner Site Tubingen, Tubingen, Germany

[13] Acad Med Ctr, Dept Radiat Oncol, Amsterdam, Netherlands

[14] Univ Hosp Zurich, Zurich, Switzerland

[15] Rambam Hlth Care Campus, Haifa, Israel

[16] Netherlands Canc Inst, Amsterdam, Netherlands

来源：

JOURNAL OF CLINICAL ONCOLOGY | 2018年 / 36卷 / 15期

关键词：

D O I：

10.1200/JCO.2018.36.15_suppl.504

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

504

引用

页数：1